 | | PRD_002384 | | Formula: | C58 H95 N15 O15 | | Definition date: | 2022-08-03 | | Last modified: | 2022-08-03 |
|
 | | PRD_000468 | | Name: | Allosamidin | | Formula: | C25 H42 N4 O14 | | Definition date: | 2015-07-18 | | Last modified: | 2022-03-03 |
|
 | | PRD_002479 | | Name: | Cyclic Peptide Inhibitor ZO1-GLN-SER-TPO-45W-MLL | | Formula: | C34 H48 F3 N6 O14 P | | Definition date: | 2022-03-02 | | Last modified: | 2022-03-02 |
|
 | | PRD_000204 | | Name: | Vancomycin | | Formula: | C66 H75 Cl2 N9 O24 | | Description: | VANCOMYCIN IS A TRICYCLIC GLYCOPEPTIDE, GLYCOSYLATED BY A DISACCHARIDE (RESIDUES 8 AND 9) ON RESIDUE 4. | | Definition date: | 2012-12-12 | | Last modified: | 2022-01-06 |
|
 | | PRD_002455 | | Name: | D-PMI-omega | | Formula: | C82 H115 Cl N17 O20 | | Definition date: | 2021-11-17 | | Last modified: | 2021-11-17 |
|
 | | PRD_002454 | | Name: | Substrate-like cysteine protease inhibitor | | Formula: | C46 H70 Cl N10 O9 | | Definition date: | 2021-09-01 | | Last modified: | 2021-09-01 |
|
 | | PRD_002469 | | Name: | Inhibitor 18 | | Formula: | C30 H42 N4 O6 | | Definition date: | 2021-08-25 | | Last modified: | 2021-08-25 |
|
 | | PRD_002457 | | Name: | beta-D-glucopyranose-(1-4)-beta-D-glucopyranose-(1-3)-2-deoxy-2-fluoro-alpha-D-glucopyranose | | Formula: | C18 H31 F O15 | | Definition date: | 2021-05-19 | | Last modified: | 2021-05-19 |
|
 | | PRD_002383 | | Name: | des4.3.1 | | Formula: | C44 H74 N12 O11 S | | Definition date: | 2021-04-28 | | Last modified: | 2021-04-28 |
|
 | | PRD_002362 | | Name: | GsIN-1 peptide | | Formula: | C79 H106 N16 O21 S | | Definition date: | 2021-04-21 | | Last modified: | 2021-04-21 |
|
 | | PRD_002397 | | Formula: | C41 H72 N14 O10 S | | Definition date: | 2021-03-31 | | Last modified: | 2021-03-31 |
|
 | | PRD_002398 | | Formula: | C42 H74 N14 O10 S | | Definition date: | 2021-03-31 | | Last modified: | 2021-03-31 |
|
 | | PRD_002399 | | Formula: | C45 H68 N10 O11 S | | Definition date: | 2021-03-31 | | Last modified: | 2021-03-31 |
|
 | | PRD_002360 | | Name: | myristoyl thiourea inhibitor, No. 23 | | Formula: | C37 H67 N9 O5 S | | Definition date: | 2021-03-24 | | Last modified: | 2021-03-24 |
|
 | | PRD_002361 | | Name: | myristoyl thiourea inhibitor, No.13 | | Formula: | C39 H73 N12 O5 S | | Definition date: | 2021-03-24 | | Last modified: | 2021-03-24 |
|
 | | PRD_002460 | | Formula: | C20 H39 N3 O5 | | Description: | Calpain I inhibitor | | Definition date: | 2021-02-24 | | Last modified: | 2021-02-24 |
|
 | | PRD_900134 | | Name: | Blood group B H type 2 antigen, beta anomer | | Formula: | C26 H45 N O20 | | Description: | oligosaccharide with branches | | Definition date: | 2021-02-17 | | Last modified: | 2021-02-17 |
|
 | | PRD_002449 | | Name: | (ACE)(1MH)D(B3L)F(1U8) | | Formula: | C44 H54 N6 O12 | | Definition date: | 2020-09-30 | | Last modified: | 2020-09-30 |
|
 | | PRD_002450 | | Name: | (ACE)(1MH)D(PF5)F(1U8) | | Formula: | C46 H45 F5 N6 O12 | | Definition date: | 2020-09-30 | | Last modified: | 2020-09-30 |
|
 | | PRD_002372 | | Name: | ACE-VAL-ARG-MET-QZA | | Formula: | C22 H43 Cl N7 O5 S | | Definition date: | 2020-09-16 | | Last modified: | 2020-09-16 |
|
 | | PRD_002373 | | Name: | ACE-VAL-ARG-MET-B2A | | Formula: | C20 H41 B N7 O6 S | | Definition date: | 2020-09-16 | | Last modified: | 2020-09-16 |
|
 | | PRD_002352 | | Formula: | C22 H31 N3 O7 | | Definition date: | 2020-09-02 | | Last modified: | 2020-09-02 |
|
 | | PRD_002315 | | Name: | 4HP-PRO-LYS-ARG-NH2, BM-30 | | Formula: | C25 H42 N8 O5 | | Definition date: | 2020-08-26 | | Last modified: | 2020-08-26 |
|
 | | PRD_002267 | | Name: | D-Arg4,Leu10-Teixobactin | | Formula: | C59 H101 N14 O14 | | Definition date: | 2020-08-19 | | Last modified: | 2020-08-19 |
|
 | | PRD_002187 | | Name: | tert-butyl [(4S,7S,10S)-7-(cyclohexylmethyl)-10-(hydroxymethyl)-5,8,13-trioxo-23-oxa-6,9,14,21,22-pentaazabicyclo[18.2.1]tricosa-1(22),20-dien-4-yl]carbamate | | Formula: | C30 H50 N6 O7 | | Definition date: | 2020-08-12 | | Last modified: | 2020-08-12 |
|
